{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T12:45:21Z","timestamp":1695213921102},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Motivation: New efforts to guide and prioritize the selection of cancer drug targets are urgently needed, as is evident by the slow development of novel anti-cancer agents and the narrow therapeutic index of existing drugs. Given these limitations, the current study was conducted to explore the classification features defining the therapeutic success that can result from targeting a particular gene.<\/jats:p>\n               <jats:p>Results: Classification was based on extracting features specific to known successful anti-cancer targets and combining them in a linear classifier, resulting in calculation of an enrichment score for each gene. Extended description, the search tool used in this study, enriched existing drug target candidates by up to 10-fold at an \u223c50% recall rate, covering \u223c24 000 genes or \u223c80% of genome. More importantly, the target category with high attrition rate was classified from target category with low attrition rate, allowing to refine the drug development portfolios. Biological relevance of the parameters comprising the enrichment score was explored. Enrichment in cancer-specific effects was independently demonstrated by literature analysis. Imposing these enrichment scores on existing structural, pathway and phenotype-based procedures for prospective target selection may enhance the efficiency and accuracy of target identification and accelerate drug design.<\/jats:p>\n               <jats:p>Availability: The software used in this work is available upon request.<\/jats:p>\n               <jats:p>Contact: \u00a0amayburd@cpaglobal.com, James_L_Mulshine@rush.edu<\/jats:p>\n               <jats:p>Supplementary information: Supplementary data are available at www.mayburd.com; http:\/\/www.rush.edu\/rumc\/page-1120170920643.html<\/jats:p>","DOI":"10.1093\/bioinformatics\/btm447","type":"journal-article","created":{"date-parts":[[2007,10,10]],"date-time":"2007-10-10T00:24:37Z","timestamp":1191975877000},"page":"389-395","source":"Crossref","is-referenced-by-count":8,"title":["Successful anti-cancer drug targets able to pass FDA review demonstrate the identifiable signature distinct from the signatures of random genes and initially proposed targets"],"prefix":"10.1093","volume":"24","author":[{"given":"Anatoly L.","family":"Mayburd","sequence":"first","affiliation":[{"name":"1 CPA Global, LLC, 1725 Duke Street, Alexnadria, VA 22314, 2IGMZ consulting, 456 Washington Avenue, Belleville, NJ 07109 and 3Rush University Medical Center, Chicago, IL 60612, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna","family":"Golovchikova","sequence":"additional","affiliation":[{"name":"1 CPA Global, LLC, 1725 Duke Street, Alexnadria, VA 22314, 2IGMZ consulting, 456 Washington Avenue, Belleville, NJ 07109 and 3Rush University Medical Center, Chicago, IL 60612, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James L.","family":"Mulshine","sequence":"additional","affiliation":[{"name":"1 CPA Global, LLC, 1725 Duke Street, Alexnadria, VA 22314, 2IGMZ consulting, 456 Washington Avenue, Belleville, NJ 07109 and 3Rush University Medical Center, Chicago, IL 60612, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,10,8]]},"reference":[{"key":"2023061011433819400_B1","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1073\/pnas.102102699","article-title":"Selection bias in gene extraction on the basis of microarray gene-expression data","volume":"99","author":"Ambroise","year":"2002","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2023061011433819400_B2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrd1754","article-title":"Can cell systems biology rescue drug discovery?","volume":"4","author":"Butcher","year":"2005","journal-title":"Nat. Rev. Drug Discov"},{"key":"2023061011433819400_B3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/gcc.20283","article-title":"Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?","volume":"45","author":"Casc\u00f3n","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"2023061011433819400_B4","first-page":"949","article-title":"Targeting mutated protein tyrosine kinases and their signaling pathways in hematologic malignancies","volume":"90","author":"Chalandon","year":"2005","journal-title":"Haematologica"},{"key":"2023061011433819400_B5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/nar\/30.1.412","article-title":"TTD: Therapeutic Target Database","volume":"30","author":"Chen","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"2023061011433819400_B6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1160\/ME0425","article-title":"Does drug-target have a likeness?","volume":"46","author":"Chen","year":"2007","journal-title":"Methods Inf. Med"},{"key":"2023061011433819400_B7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/1097-0134(20010501)43:2<217::AID-PROT1032>3.0.CO;2-G","article-title":"Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule","volume":"43","author":"Chen","year":"2001","journal-title":"Proteins"},{"key":"2023061011433819400_B8","first-page":"303","article-title":"Support vector machines approach for predicting druggable proteins: recent progress in its exploration and investigation of its usefulness","volume":"12","author":"Chen","year":"2007","journal-title":"Drug Discov. Today"},{"key":"2023061011433819400_B9","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0958-1669(00)00151-8","article-title":"Applied genomics: integration of the technology within pharmaceutical research and development","volume":"11","author":"Cockett","year":"2000","journal-title":"Curr. Opin. Biotechnol"},{"key":"2023061011433819400_B10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S1359-6446(05)03451-3","article-title":"The transcriptome's drugable frequenters","volume":"10","author":"Dechering","year":"2006","journal-title":"Drug Discov. Today"},{"key":"2023061011433819400_B11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0167-6296(02)00126-1","article-title":"The price of innovation: new estimates of drug development costs","volume":"22","author":"DiMasi","year":"2003","journal-title":"J. Health Econ"},{"key":"2023061011433819400_B12","article-title":"Linear discriminant function","volume-title":"Pattern Classification.","author":"Duda","year":"2001"},{"key":"2023061011433819400_B13","article-title":"Stopped training","volume-title":"Pattern Classification..","author":"Duda","year":"2001"},{"key":"2023061011433819400_B14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1073\/pnas.0407790101","article-title":"Biological spectra analysis: linking biological activity profiles to molecular structure","volume":"102","author":"Fliri","year":"2005","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2023061011433819400_B15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrc1299","article-title":"A census of human cancer genes","volume":"4","author":"Futreal","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"2023061011433819400_B16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2174\/1568011033482422","article-title":"Signal transduction pathways of taxanes-induced apoptosis","volume":"3","author":"Ganansia-Leymarie","year":"2003","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"2023061011433819400_B17","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.1632587100","article-title":"Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro","volume":"100","author":"Gunther","year":"2003","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2023061011433819400_B18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.drudis.2007.02.015","article-title":"Support vector machines approach for predicting druggable proteins: recent progress in its exploration and investigation of its usefulness","volume":"12","author":"Han","year":"2007","journal-title":"Drug Discov. Today"},{"key":"2023061011433819400_B19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1371\/journal.pcbi.0020061","article-title":"Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis","volume":"2","author":"Hasan","year":"2006","journal-title":"PLoS Comput. Biol"},{"issue":"Database issue","key":"2023061011433819400_B20","doi-asserted-by":"crossref","first-page":"D721","DOI":"10.1093\/nar\/gkl811","article-title":"Cancer genes: a gene selection resource for cancer genome projects","volume":"35","author":"Higgins","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"2023061011433819400_B21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/gcc.20156","article-title":"Alterations of pre-mRNA splicing in cancer","volume":"42","author":"Kalnina","year":"2005","journal-title":"In Genes Chromosomes Cancer"},{"key":"2023061011433819400_B22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature01913","article-title":"A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors","volume":"425","author":"Kamal","year":"2003","journal-title":"Nature"},{"key":"2023061011433819400_B23","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/0003-4819-138-10-200305200-00010","article-title":"Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics","volume":"138","author":"Kurzrock","year":"2003","journal-title":"Ann. Intern. Med"},{"key":"2023061011433819400_B24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrd1722","article-title":"Cancer drug discovery through collaboration","volume":"4","author":"Lengauer","year":"2005","journal-title":"Nat. Rev. Drug Discov"},{"key":"2023061011433819400_B25","doi-asserted-by":"crossref","first-page":"16013","DOI":"10.1073\/pnas.0500090102","article-title":"The response of autologous T cells to a human melanoma is dominated by mutated neoantigens","volume":"102","author":"Lennerz","year":"2005","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2023061011433819400_B26","doi-asserted-by":"crossref","first-page":"W219","DOI":"10.1093\/nar\/gkl114","article-title":"TarFisDock: a web server for identifying drug targets with docking approach","volume":"34","author":"Li","year":"2006","journal-title":"Nucleic Acid Res"},{"key":"2023061011433819400_B27","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.cell.2006.01.040","article-title":"A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen","volume":"124","author":"Moffat","year":"2006","journal-title":"Cell"},{"key":"2023061011433819400_B28","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1021\/jm060902w","article-title":"Bridging chemical and biological spaces: \u201ctarget fishing\u201d using 2D and 3D molecular descriptors","volume":"49","author":"Nettles","year":"2006","journal-title":"J. Med. Chem"},{"key":"2023061011433819400_B29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nature02580","article-title":"Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy","volume":"429","author":"Oh","year":"2004","journal-title":"Nature"},{"key":"2023061011433819400_B30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.exphem.2006.03.002","article-title":"Oncolytic measles virus targets high CD46 expression on multiple myeloma cells","volume":"34","author":"Ong","year":"2006","journal-title":"Exp. Hematol"},{"key":"2023061011433819400_B31","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1479-828X.2006.00623.x","article-title":"Customised birthweight: coefficients for an Australian population and validation of the model","volume":"46","author":"Pain","year":"2006","journal-title":"Aust. N. Z. J. Obstet. Gynaecol"},{"key":"2023061011433819400_B32","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/prot.10625","article-title":"Recovering the true targets of specific ligands by virtual screening of the protein data bank","volume":"54","author":"Paul","year":"2004","journal-title":"Proteins"},{"key":"2023061011433819400_B33","doi-asserted-by":"crossref","first-page":"9309","DOI":"10.1073\/pnas.0401994101","article-title":"Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression","volume":"101","author":"Rhodes","year":"2004","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2023061011433819400_B34","first-page":"246","article-title":"Glivec and CML: a lucky date","volume":"18","author":"Saglio","year":"2004","journal-title":"J. Biol. Regul. Homeost Agents"},{"key":"2023061011433819400_B35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/j.1538-7305.1948.tb01338.x","article-title":"A mathematical theory of communication","volume":"27","author":"Shannon","year":"1948","journal-title":"Bell Syst. Tech. J"},{"key":"2023061011433819400_B36","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/431915a","article-title":"Human genome: end of the beginning","volume":"431","author":"Stein","year":"2004","journal-title":"Nature"},{"key":"2023061011433819400_B37","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1359-6446(05)03590-7","article-title":"Biology calls the targets: combining RNAi and disease biology","volume":"10","author":"van Es","year":"2005","journal-title":"Drug Discov. Today"},{"key":"2023061011433819400_B38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrd987","article-title":"Knockouts model the 100 best-selling drugs\u2013will they model the next 100?","volume":"2","author":"Zambrowicz","year":"2003","journal-title":"Nat. Rev. Drug Discov"},{"key":"2023061011433819400_B39","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.drudis.2006.03.012","article-title":"Progress and problems in the exploration of therapeutic targets","volume":"11","author":"Zheng","year":"2006","journal-title":"Drug Discov. Today"},{"key":"2023061011433819400_B40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1124\/pr.58.2.4","article-title":"Therapeutic targets: progress of their exploration and investigation of their characteristics","volume":"58","author":"Zheng","year":"2006","journal-title":"Pharmacol. Rev"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/24\/3\/389\/50567806\/bioinformatics_24_3_389.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/24\/3\/389\/50567806\/bioinformatics_24_3_389.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T11:44:11Z","timestamp":1686397451000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/24\/3\/389\/252591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,8]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btm447","relation":{},"ISSN":["1367-4811","1367-4803"],"issn-type":[{"value":"1367-4811","type":"electronic"},{"value":"1367-4803","type":"print"}],"subject":[],"published-other":{"date-parts":[[2008,2,1]]},"published":{"date-parts":[[2007,10,8]]}}}